八十岁及以上患者全主动脉弓置换术:单中心18年经验
该单中心回顾性研究比较了740例全主动脉弓置换术中139例≥80岁患者与601例<80岁患者的早期和晚期结局。≥80岁组手术死亡率为8.6%,显著高于<80岁组的4.0%,但随时间显著改善;≥80岁组5年总体生存率为55.4%±5.0%,8年为32.2%±6.1%,再手术累积发生率显著低于年轻组。
要点
- ≥80岁患者全弓置换手术死亡率8.6%,高于年轻组的4.0%
- 高龄组手术死亡率随时间显著改善(P=.010)
- 高龄组再手术累积发生率显著低于年轻组(5年8.7% vs 14.2%)
核心结论
- 在八十岁及以上患者中施行全主动脉弓置换术可获得可接受的总体生存率,尽管手术死亡率高于年轻患者。
- 高龄患者再手术负担低于年轻患者。
研究设计与样本
- 单中心18年回顾性队列研究,纳入1999年10月至2018年3月共740例全主动脉弓置换术患者。
- ≥80岁组139例(年龄83.1±2.8岁),<80岁组601例(年龄66.9±11.3岁),比较两组早期和晚期结局。
主要发现
- ≥80岁组手术死亡12例(8.6%),且随时间显著改善(P=.010)。
- ≥80岁组手术死亡率显著高于<80岁组(4.0%)(P=.033)。
- ≥80岁组深部胸骨伤口感染、肺炎和气管造口术的发生患者数显著更多。
- ≥80岁组晚期死亡52例,其中主动脉相关死亡4例;5年总体生存率55.4%±5.0%,8年32.2%±6.1%。
- 多变量Cox风险回归显示,慢性肾脏病、非择期手术和同期手术是≥80岁组总体生存的显著危险因素。
临床怎么用
- 对八十岁及以上患者行全主动脉弓置换术需权衡较高的手术死亡率与可接受的远期生存。
- 术前应关注慢性肾脏病、非择期手术及同期手术等影响生存的危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluates our 18-year experience of total arch replacement in the octogenarian and nonagenarian population. METHODS: Between October 1999 and March 2018, a total of 740 patients underwent total arch replacement at our institution. A total of 139 patients were aged 80 years or more (83.1 ± 2.8 years), and 601 patients were aged less than 80 years (66.9 ± 11.3 years). Early and late outcomes were compared between the groups. RESULTS: In the group aged 80 years or more, operative mortality occurred in 12 patients (8.6%) and significantly improved over time (P = .010). Operative mortality was significantly higher in the group aged 80 years or more (P = .033) when compared with the group aged less than 80 years (4.0%). Regarding postoperative complications, deep sternal wound infection, pneumonia, and tracheostomy occurred in significantly more patients in the group aged 80 years or more. In the group aged 80 years or more, there were 52 late deaths, with 4 aortic-related deaths. Overall survival was 55.4% ± 5.0% at 5 years and 32.2% ± 6.1% at 8 years. Multivariable Cox-hazard regression analysis demonstrated that chronic kidney disease, nonelective surgery, and concurrent procedures were significant risk factors for overall survival in the group aged 80 years or more. Cumulative incidence for reoperation was significantly lower in the group aged 80 years or more (8.7% at 5 years) compared with the group aged less than 80 years (14.2% at 5 years). CONCLUSIONS: Total arch replacement was performed with an acceptable overall survival in octogenarians and nonagenarians, although operative mortality was higher than in younger patients. However, older patients had a lesser burden of reoperation compared with younger patients.
引用
- Ikeno Y, Yokawa K, Yamanaka K, et al. Total arch replacement in octogenarians and nonagenarians: A single-center 18-year experience. J Thorac Cardiovasc Surg. 2019. PMID: 31562010. doi:10.1016/j.jtcvs.2019.07.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。